Advertisement
Danaher Corporation

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DHRNYSE
HealthcareMedical - Diagnostics & Research
$183.63
$4.78(2.54%)
U.S. Market opens in 16h 16m
Advertisement

Danaher Corporation (DHR)

Meyka AI Score

Z

Key Financials

Market Cap130B
P/E Ratio36.20
EPS (TTM)$5.16
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$185.02
3 Months$178.96
1 Year Target$219.51

DHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $219.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.20 and a market capitalization of 130B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.53%
5-Day Change
-2.32%
1-Month Change
7.29%
3-Month Change
-5.93%
6-Month Change
-20.30%
Year-to-Date (YTD) Change
-19.78%
1-Year Change
-9.37%
3-Year Change
-12.97%
5-Year Change
-15.87%
All-Time (Max) Change
30727.08%

Contact Information

202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

61,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions